Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Accenture
McKesson
Cipla
Federal Trade Commission
UBS
Novartis
US Army
Boehringer Ingelheim

Generated: December 12, 2017

DrugPatentWatch Database Preview

Ixabepilone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ixabepilone and what is the scope of ixabepilone freedom to operate?

Ixabepilone
is the generic ingredient in one branded drug marketed by R-pharm Us Llc and is included in one NDA. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for ixabepilone. One supplier is listed for this compound.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
R-pharm Us LlcIXEMPRA KITixabepiloneINJECTABLE;IV (INFUSION)022065-001Oct 16, 2007RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
R-pharm Us LlcIXEMPRA KITixabepiloneINJECTABLE;IV (INFUSION)022065-001Oct 16, 2007RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
R-pharm Us LlcIXEMPRA KITixabepiloneINJECTABLE;IV (INFUSION)022065-002Oct 16, 2007RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
R-pharm Us LlcIXEMPRA KITixabepiloneINJECTABLE;IV (INFUSION)022065-001Oct 16, 2007RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
R-pharm Us LlcIXEMPRA KITixabepiloneINJECTABLE;IV (INFUSION)022065-002Oct 16, 2007RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
R-pharm Us LlcIXEMPRA KITixabepiloneINJECTABLE;IV (INFUSION)022065-001Oct 16, 2007RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
R-pharm Us LlcIXEMPRA KITixabepiloneINJECTABLE;IV (INFUSION)022065-001Oct 16, 2007RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
R-pharm Us LlcIXEMPRA KITixabepiloneINJECTABLE;IV (INFUSION)022065-002Oct 16, 2007RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
R-pharm Us LlcIXEMPRA KITixabepiloneINJECTABLE;IV (INFUSION)022065-002Oct 16, 2007RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
R-pharm Us LlcIXEMPRA KITixabepiloneINJECTABLE;IV (INFUSION)022065-002Oct 16, 2007RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Harvard Business School
Express Scripts
Mallinckrodt
Boehringer Ingelheim
Julphar
Farmers Insurance
Johnson and Johnson
Accenture
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot